Treatment of multidrug-resistant Pseudomonas aeruginosa infections: more attention required to in-vitro studies.
Zavascki
A P
AP
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination; D006801:Humans; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000635:transmission; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000254:growth & development
D000900:Anti-Bacterial Agents